GLAND PHARMA LIMITED
Event Details
The Company will host an Earnings Conference Call for Q1 FY27 (quarter ended June 30, 2026) on Monday, August 10, 2026 at 18:30 hours (IST). The call is scheduled to last for 60 minutes.
Purpose and Agenda
The management team will discuss the Company's financial performance and provide business updates for the quarter ended June 30, 2026. The call will include a question and answer session related to the business.
Post-Call Availability
The transcript and audio recording of the Earnings Call will be made available on the Company's website at www.glandpharma.com after the call concludes.
Dial-In Information
Multiple access options are provided for participants:
- Diamond pass link: Registration required
- Universal Access: +91 22 7115 8875
- International Toll-Free Numbers:
- USA: 18667462133
- UK: 08081011573
- Singapore: 8001012045
- Hong Kong: 800964448
Company Contacts
- Sampath Kumar Pallerlamudi: Company Secretary & Compliance Officer
- Shriniwas Pradeep Dange: Investor Relations
- Contact email: investors@glandpharma.com